DGAP-News: novoGI(TM) Announces Purchase of IP and Collaboration With Leading Gastroenterologist Dr. Christopher Paul Swain

novoGI Inc. 

14.06.2012 15:37
---------------------------------------------------------------------------

Innovative Bariatric Compression Procedure to be Jointly Developed

ATLANTA, 2012-06-14 15:37 CEST (GLOBE NEWSWIRE) --
novoGI Inc. today announced that it has purchased IP and signed a collaboration
agreement with Dr. C.P. Swain for the joint development of an innovative
laparoscopic nitinol based compression anastomosis solution for Bariatric
surgery. Professor Paul Swain is Professor of Gastrointestinal Endoscopy at
Imperial College, London University, UK. Professor Swain is widely published in
the area of gastroenterology, with over 180 publications on areas such as
endoscopy, gastrointestinal bleeding and technical advances and devices for
endoscopy. 

'I am thrilled to be working again with Gavriel Meron and the novoGI
development team to provide a unique solution for the growing need for a
simpler and safer bariatric surgical procedure,' commented Dr. Swain.
'Bariatric surgery often is the best path for resolving obesity and Type 2
Diabetes, and we believe that our innovative solution may significantly improve
outcomes and quality of life, thereby becoming the standard of care worldwide.' 

'We are delighted to be collaborating with Dr. Swain. A prototype has already
been successfully tested in pre-clinical studies and we look forward to jointly
developing this solution,' said Gavriel D. Meron, President and Chief Executive
Officer of novoGI. 'We see this agreement as another important step in
expanding our offerings in line with our focus on advancing patient care and
seeking better outcomes through our comprehensive approach to GI disease
management.' 

About Dr. Christopher Paul Swain

Professor Paul Swain trained in Oxford and London University and specialized in
gastroenterology, doing his MD on the use of therapeutic endoscopy for the
treatment of gastrointestinal bleeding. Subsequent posts included a DHSS-funded
Clinical Research Fellowship to study the effect of lasers in gastrointestinal
hemorrhage.  In 1987, he was appointed as Senior Lecturer and Consultant in
Gastroenterology at the Royal London Hospital. In 1999, he was appointed to
become Professor of Gastrointestinal Endoscopy to London University. In 2003,
he moved to Imperial College in London University. 

Professor Swain has contributed chapters to key clinical textbooks such as the
Textbook of Gastroenterology (Ed: T Yamada) and Clinical Gastroenterology,
Endoscopy: New Techniques in Diagnosis and Therapy (Ed: H D Allescher and M
Classen). He is a named inventor of numerous issued patents of devices for
flexible endoscopic gastrointestinal surgery. His work has resulted in a number
of postgraduate honors, including the Medal of Padua University, the Medal of
the Danish Surgical Society, the Hopkins prize of British Society of
Gastroenterology on two separate occasions, the Medal of the University of
Rome, the Schindler award of the American Society of Gastrointestinal
Endoscopy. He contributed to the invention and development of endoscopic sewing
devices, the wireless capsule endoscope and new methods and devices for
less-invasive surgery including bariatric and laparoscopic surgery. 

About novoGI

novoGI is focused on expanding its range of device driven solutions for GI
disease management through a globally branded, high quality, market driven
company. The US headquarters are in Atlanta, Georgia; research, development and
manufacturing facilities in Netanya, Israel; and its European headquarters near
Paris, France. For more information, visit www.novogi.com. 


         CONTACT: marcom@novoGI.com
         www.novoGI.com
News Source: NASDAQ OMX



14.06.2012 Dissemination of a Corporate News, transmitted by DGAP - 
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      novoGI Inc.
              
               
              Israel
Phone:        
Fax:          
E-mail:       
Internet:     
ISIN:         US9902064198
WKN:          
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------